TCL Archive In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div. February 28, 1992
TCL Archive Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT April 29, 1994
TCL Archive Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA. October 28, 2005
TCL Archive CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans. November 5, 2004
